Formycon AG

Formycon AG is a leading, independent developer of high-quality biosimilar pharmaceuticals, particularly in the area of biosimilars. The company has a team of over 240 experienced specialists dedicated to developing complex medicines across the entire value chain. Their expertise spans technical-pharmaceutical development, clinical trials, and preparation of dossiers for regulatory approval. Formycon focuses on treatments for ophthalmology and immunology, as well as other important chronic diseases.

Formycon aims to make vital medicines accessible to a wider range of patients by developing biosimilars that meet the stringent standards of major global markets, including the European Union, the United States, Canada, Japan, and Australia. The company's unique expertise stems from its team of scientists, managers, and board members who have successfully brought biosimilars to market. Their collective experience and expertise encompass all stages of development, from market analysis and protein analytics to production process development, clinical trials, and regulatory approval.

Formycon offers flexible working hours to accommodate employees' schedules, enabling them to balance work and personal life. They also support hybrid work arrangements, allowing employees to work from both the office and home, promoting flexibility and a better work-life balance.

Formycon AG offers employees a comprehensive benefits package that includes flexible working hours, hybrid work options, 30 days of paid vacation, a company pension plan, group accident insurance, a company card, and opportunities for continuing education. These benefits aim to create a supportive and stimulating work environment that promotes employee well-being and professional development.

Formycon AG is a leading, independent developer of high-quality biosimilar drugs, with a focus on ophthalmology and immunology therapies. Their mission is to provide broad patient access to affordable, high-quality biopharmaceuticals by developing biosimilars that are proven to be safe, effective and cost-efficient. Formycon operates on a global scale and its unique expertise in the biosimilar field enables them to navigate the entire drug development process from early analysis to regulatory approval.

Formycon cultivates a culture of diversity and mutual appreciation, emphasizing professionalism and team spirit. They offer a dynamic and fast-paced work environment with opportunities for rapid career advancement, where employees are encouraged to bring their unique skills and perspectives to the table.

Formycon cultivates a diverse and inclusive workplace by fostering a culture of mutual appreciation and respect. The company believes that this approach contributes significantly to its success and progress. They offer opportunities for rapid career advancement in a dynamic, high-growth environment, emphasizing professionalism and team spirit as fundamental to their daily collaboration.